BRPI0406911A - Produto farmacêutico e/ou cosmético - Google Patents

Produto farmacêutico e/ou cosmético

Info

Publication number
BRPI0406911A
BRPI0406911A BR0406911-0A BRPI0406911A BRPI0406911A BR PI0406911 A BRPI0406911 A BR PI0406911A BR PI0406911 A BRPI0406911 A BR PI0406911A BR PI0406911 A BRPI0406911 A BR PI0406911A
Authority
BR
Brazil
Prior art keywords
formulations
pharmaceutical
cosmetic product
dispense
active ingredient
Prior art date
Application number
BR0406911-0A
Other languages
English (en)
Inventor
Koral Embil
Sergio Nacht
Original Assignee
Edko Trading Representation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Edko Trading Representation filed Critical Edko Trading Representation
Publication of BRPI0406911A publication Critical patent/BRPI0406911A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/327—Peroxy compounds, e.g. hydroperoxides, peroxides, peroxyacids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
    • B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
    • B65D81/00—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents
    • B65D81/32—Containers, packaging elements, or packages, for contents presenting particular transport or storage problems, or adapted to be used for non-packaging purposes after removal of contents for packaging two or more different materials which must be maintained separate prior to use in admixture
    • B65D81/3283—Cylindrical or polygonal containers, e.g. bottles, with two or more substantially axially offset, side-by-side compartments for simultaneous dispensing
    • B65D81/3288—Cylindrical or polygonal containers, e.g. bottles, with two or more substantially axially offset, side-by-side compartments for simultaneous dispensing composed of two or more separate containers joined to each other
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/88—Two- or multipart kits

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Emergency Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Vascular Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Containers And Packaging Bodies Having A Special Means To Remove Contents (AREA)

Abstract

"PRODUTO FARMACêUTICO E/OU COSMéTICO". A invenção fornece um produto farmacêutico e/ou cosmético compreendendo um primeiro e um segundo ingrediente ativo contendo formulações para administração tópica a um paciente, onde o mencionado produto inclui meios de armazenagem onde as mencionadas formulações são mantidas separadas antes da dispensação, juntamente com meios de dosagem que permitem que as mencionadas formulações sejam dispensadas dos mencionados meios de armazenagem, caracterizado pelo fato de que (i) um ingrediente ativo em pelo menos uma das mencionadas formulações está contido dentro de um sistema de distribuição polimérico (por exemplo, um sistema de distribuição de micro-esponjas) e (ii) ambas as mencionadas formulações compreendem bases carreadoras à base de água (por exemplo, aquosos) tendo substancialmente a mesma lipofilicidade. Também fornece um sistema de dispensação de câmara dupla ou câmara múltipla adequado para dispensar as mencionadas formulações que são fornecidas com um fecho removível, por exemplo, uma tampa. Esse fecho evita que as formulações sejam acidentalmente dispensadas por um orifício de dispensação e pode também reduzir a exposição desses orifícios ao ar. Os produtos da invenção são particularmente adequados para dispensar formulações para tratamento de condições dermatológicas tais como acne, em particular formulações nas quais os componentes ativos têm limitações de estabilidade quando combinadas, por exemplo aquelas compreendendo antibacterianos oxidantes (por exemplo peróxido de benzoíla) e antibióticos.
BR0406911-0A 2003-01-23 2004-01-23 Produto farmacêutico e/ou cosmético BRPI0406911A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0301577.3A GB0301577D0 (en) 2003-01-23 2003-01-23 Topical pharmaceutical and/or cosmetic dispense systems
PCT/GB2004/000288 WO2004064803A1 (en) 2003-01-23 2004-01-23 Topical pharmaceutical and/or cosmetic dispense systems

Publications (1)

Publication Number Publication Date
BRPI0406911A true BRPI0406911A (pt) 2006-01-03

Family

ID=9951680

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0406911-0A BRPI0406911A (pt) 2003-01-23 2004-01-23 Produto farmacêutico e/ou cosmético

Country Status (18)

Country Link
US (1) US20040157766A1 (pt)
EP (1) EP1589945B1 (pt)
JP (1) JP4898423B2 (pt)
KR (1) KR101224065B1 (pt)
CN (1) CN1764437B (pt)
AT (1) ATE509616T1 (pt)
AU (1) AU2004206101B2 (pt)
BR (1) BRPI0406911A (pt)
CA (1) CA2514019C (pt)
DK (1) DK1589945T3 (pt)
EA (1) EA008813B1 (pt)
GB (1) GB0301577D0 (pt)
HK (1) HK1088540A1 (pt)
MA (1) MA27586A1 (pt)
MX (1) MXPA05007785A (pt)
NZ (1) NZ541370A (pt)
WO (1) WO2004064803A1 (pt)
ZA (1) ZA200505925B (pt)

Families Citing this family (58)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7820186B2 (en) * 2001-12-21 2010-10-26 Galderma Research & Development Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
US20040167223A1 (en) * 2002-09-03 2004-08-26 Popp Karl F. Topical antibacterial formulations
US20040171561A1 (en) * 2002-09-03 2004-09-02 Popp Karl F. Topical formulations for treatment of rosacea
GB0222522D0 (en) 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
JP2008519764A (ja) * 2004-11-09 2008-06-12 イマジナティブ リサーチ アソシエィツ インコーポレーテッド レチノイド溶液及びそれからつくった調合物
US20100203088A1 (en) * 2005-06-08 2010-08-12 Khandelwal Sanjeev Silver Nanoparticle Dispersion Formulation
AR054805A1 (es) * 2005-06-29 2007-07-18 Stiefel Laboratories Composiciones topicas para el tratamiento de la piel
EP2431088A1 (en) 2005-08-02 2012-03-21 Sol-Gel Technologies Ltd. Metal oxide coating of water insoluble ingredients
ES2313267T3 (es) * 2005-09-16 2009-03-01 Italfar Societa A Responsabilita Limitata Composicion farmaceutica de cicatrizacion de heridas que comprende sucralfato, glicina, acetato de aluminio y vitaminas.
US8147815B2 (en) * 2005-12-16 2012-04-03 Celmatrix Corporation Topical administration carrier composition and therapeutic formulations comprising same
WO2007092312A2 (en) * 2006-02-03 2007-08-16 Stiefel Laboratories, Inc. Topical skin treating compositions
KR101368107B1 (ko) 2006-03-31 2014-03-14 스티펠 리서치 오스트레일리아 피티와이 리미티드 발포성 현탁겔
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
BRPI0713203A2 (pt) * 2006-07-12 2012-04-03 Controlled Therapeutics Scotland Ltda inserto, métodos, embalagem, dispositivo recuperável e dispositivo inserìvel
FR2903603B1 (fr) * 2006-07-13 2009-03-20 Galderma Res & Dev S N C Snc Combinaison d'adapalene et de peroxyde de benzole dans le traitement de l'acne
US8080537B2 (en) * 2006-07-13 2011-12-20 Galderma Research & Development Combinations of adapalene and benzoyl peroxide for treating acne lesions
US20100183688A1 (en) * 2006-07-24 2010-07-22 Amcol International Corporation Delivery System and Method of Manufacturing the Same
MXPA06008988A (es) * 2006-08-08 2008-02-07 Fernando Ahumada Ayala Preparaciones topicas antiacne que contienen retinoide (tazaroteno o adapaleno), antibiotico (fosfato de clindamicina) y/o queratolitico (peroxido de bonzoilo en microesponjas).
US7604814B2 (en) * 2006-08-29 2009-10-20 Karykion Inc. Method of removing ticks from the epidermal tissue of humans and other mammals
US8323672B2 (en) 2006-08-29 2012-12-04 Karykion Corporation Method of removing ticks from the skin and reducing the risk of bites
GB0618697D0 (en) * 2006-09-22 2006-11-01 Syntopix Ltd Formulations
GB0620685D0 (en) 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
FR2910321B1 (fr) 2006-12-21 2009-07-10 Galderma Res & Dev S N C Snc Gel creme comprenant au moins un retinoide et du peroxyde de benzole
CA2824842C (en) * 2007-02-01 2016-10-11 Sol-Gel Technologies Ltd. Method for preparing particles comprising metal oxide coating and particles with metal oxide coating
ES2912051T3 (es) 2007-02-01 2022-05-24 Sol Gel Tech Ltd Composiciones para aplicación tópica que comprenden un peróxido y retinoide
US20080188446A1 (en) * 2007-02-02 2008-08-07 Warner Chilcott Company Inc. Tetracycline compositions for topical administration
US8668913B2 (en) * 2007-02-09 2014-03-11 Personal Products Company Complementary personal lubricant compositions
US20080287373A1 (en) * 2007-05-17 2008-11-20 Popp Karl F Topical skin treating kits
US8275441B2 (en) * 2007-11-02 2012-09-25 Tyco Healthcare Group Lp Electrodes possessing change indicator
US20100330007A1 (en) * 2008-02-01 2010-12-30 Amcol International Corporation Imrpoved Skin Brightening Compositions
EP2288349A1 (en) * 2008-05-16 2011-03-02 Galderma Research & Development Therapy regimen for treating acne related diseases
WO2009156679A1 (fr) * 2008-05-30 2009-12-30 Galderma Research & Development Compositions depigmentantes anhydres comprenant, au sein de la phase grasse un derive phenolique solubilise et un retinoide
US7740886B1 (en) * 2008-07-11 2010-06-22 Sara Vargas Bedsore treatment ointment
WO2010033408A1 (en) * 2008-09-17 2010-03-25 Mcgrath Patrick D Antimicrobial sucralfate paste methods and compositions
WO2010047831A1 (en) * 2008-10-23 2010-04-29 Nycomed Us Inc. Stable metronidazole gel formulations
MX2011005010A (es) * 2009-01-05 2011-05-30 Sol Gel Technologies Ltd Composiciones topicas que contienen agentes activos recubiertos.
WO2010083419A1 (en) * 2009-01-16 2010-07-22 Colgate-Palmolive Company Dispensing container comprising a pump receiving fitment
WO2011101868A2 (en) * 2010-02-18 2011-08-25 Helios Pharmaceuticals Private Limited Stable pharmaceutical preparations containing clindamycin and benzoyl peroxide and method thereof
US20120064135A1 (en) * 2010-09-15 2012-03-15 Norac Pharma Benzoyl Peroxide Composition, Methods for Making Same, and Pharmaceutical or Cosmetic Formulations Comprising Same, and Uses Thereof
CN102475681A (zh) * 2010-11-23 2012-05-30 天津金耀集团有限公司 治疗皮肤病的分离式水混悬剂药物
CN102600205B (zh) * 2011-01-19 2013-06-05 杨光明 一种治疗寻常性痤疮的“锌红过氧化苯甲酰”凝胶及其制备方法
CA2840733A1 (en) * 2011-06-30 2013-01-03 Allergan, Inc. Retinoid topical compositions and methods for treating skin conditions
US20150150279A1 (en) * 2012-07-05 2015-06-04 Wm. Wrigley Jr. Company Gum bases based on crosslinked polymeric microparticles
CN102961250B (zh) * 2012-10-10 2014-12-10 江苏山信药业有限公司 一种多组份容器及治疗痤疮的外用制剂
ES2861431T3 (es) * 2012-11-27 2021-10-06 Sol Gel Tech Ltd Composiciones para el tratamiento de la rosácea
US9687465B2 (en) 2012-11-27 2017-06-27 Sol-Gel Technologies Ltd. Compositions for the treatment of rosacea
WO2015066717A1 (en) 2013-11-04 2015-05-07 BioPharmX, Inc. Dosage form comprising an active ingredient and a plurality of solid porous microcarriers
PH12014000195A1 (en) * 2014-07-10 2017-01-23 Lao Dean Jr Preparation and composition of medium chain triglycerides containing substantial amount of lauric acid
US9962444B2 (en) 2016-09-27 2018-05-08 Shane Malek Pharmacokinetically extended action topical hair growth formulation, and administration method
MX2017003003A (es) * 2017-03-08 2018-09-07 Centro Int De Cosmiatria S A P I De C V Composición y método para el tratamiento tópico del acné severo.
MX2018001546A (es) * 2018-02-06 2019-08-07 Centro Int De Cosmiatria S A P I De C V Formulacion y metodo para el tratamiento de la alopecia androgenica.
JP6811213B2 (ja) * 2018-07-03 2021-01-13 ソル − ゲル テクノロジーズ リミテッド 酒さの治療のための組成物
US20220175802A1 (en) * 2019-03-19 2022-06-09 Sol-Gel Technologies Ltd. Combination of minocycline and benzoyl peroxide and method of use thereof
KR20210153633A (ko) * 2019-03-28 2021-12-17 티어클리어 코포레이션 안과용 제형의 흐름 제어를 위한 장치 및 방법
US11638759B2 (en) 2019-08-13 2023-05-02 Darlene E. McCord Non-activated, amorphous, pH neutral, two-part bedside-ready clay delivery system that treats pathogen infections in humans and animals
WO2023112664A1 (ja) * 2021-12-14 2023-06-22 ロート製薬株式会社 過酸化ベンゾイルを含有する医薬外用組成物

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3535422A (en) * 1968-03-11 1970-10-20 Stiefel Laboratories Stable benzoyl peroxide composition
US4056611A (en) * 1973-04-16 1977-11-01 Stiefel Laboratories, Inc. Therapeutic composition
US3969516A (en) * 1974-12-19 1976-07-13 Nelson Research & Development Company Composition and method for treatment of acne
US4497794A (en) * 1980-12-08 1985-02-05 Dermik Laboratories, Inc. Erythromycin/benzoyl peroxide composition for the treatment of acne
US4318907A (en) * 1978-04-04 1982-03-09 Westwood Pharmaceuticals, Inc. Method for treating acne vulgaris and compositions useful for that purpose
US4228163A (en) * 1979-03-30 1980-10-14 Dermik Laboratories Method for treating pseudofolliculitis barbae
US4387107A (en) * 1979-07-25 1983-06-07 Dermik Laboratories, Inc. Stable benzoyl peroxide composition
US4692329A (en) * 1980-12-08 1987-09-08 William H. Rorer, Inc. Erythromycin/benzoyl peroxide antiacne compositions
IT1210608B (it) * 1980-12-08 1989-09-14 Rorer Int Overseas Composizione per il trattamento topico dell'acne
US4411893A (en) * 1981-08-14 1983-10-25 Minnesota Mining And Manufacturing Company Topical medicament preparations
US4607101A (en) * 1981-08-27 1986-08-19 Jaye-Boern Laboratories, Inc. Method of treating acne vulgaris with a composition containing carbamide peroxide
WO1983002558A1 (en) * 1981-11-09 1983-08-04 Gail Sansone Bazzano The use of retinoids and minoxidil (2,4,-diamino-6-piperidino-pyrimidine-3-oxide) to increase the rate of growth of human scalp hair and to treat certain types of alopecias
US4923900A (en) * 1985-01-24 1990-05-08 Board Of Regents, The University Of Texas System Therapeutic compositions containing benzoyl peroxide
US4690825A (en) * 1985-10-04 1987-09-01 Advanced Polymer Systems, Inc. Method for delivering an active ingredient by controlled time release utilizing a novel delivery vehicle which can be prepared by a process utilizing the active ingredient as a porogen
US5446028A (en) * 1985-12-12 1995-08-29 Dermik Laboratories, Inc. Anti-acne method and composition
US5879716A (en) * 1985-12-18 1999-03-09 Advanced Polymer Systems, Inc. Methods and compositions for topical delivery of benzoyl peroxide
US5145675A (en) * 1986-03-31 1992-09-08 Advanced Polymer Systems, Inc. Two step method for preparation of controlled release formulations
US5955109A (en) * 1985-12-18 1999-09-21 Advanced Polymer Systems, Inc. Methods and compositions for topical delivery of retinoic acid
ZA886284B (en) * 1987-08-31 1990-04-25 Advanced Polymer Systems Inc Controlled release formulations
US4873091A (en) * 1988-05-23 1989-10-10 Advanced Polymer Systems, Inc. Controlled release formulating employing resilient microbeads
US4962170A (en) * 1989-08-31 1990-10-09 Dow Corning Corporation Method of making highly absorptive polymers
US4962133A (en) * 1989-09-05 1990-10-09 Dow Corning Corporation Method of making highly adsorptive copolymers
CA2015111A1 (en) * 1990-04-23 1991-10-23 Tom Y. Woo New binary dispensor for the application of fluids, semi-fluids or semi-solids
US5256400A (en) * 1991-12-04 1993-10-26 Advanced Polymer Systems, Inc. Pressurized product delivery systems
US6117843A (en) * 1992-02-18 2000-09-12 Lloyd J. Baroody Compositions for the treatment of acne containing clindamycin and benzoyl peroxide
TW203552B (en) * 1992-02-18 1993-04-11 J Baroody Lloyd Compositions of clindamycin and benzoyl peroxide for acne treatment
US5356040A (en) * 1992-03-31 1994-10-18 Maplast S.R.L. Container particulary for multicomponent products
US5466446A (en) * 1994-02-16 1995-11-14 Stiefel Laboratories, Inc. Topical compositions containing bensoyl peroxide and clindamycin and method of use thereof
US5837790A (en) * 1994-10-24 1998-11-17 Amcol International Corporation Precipitation polymerization process for producing an oil adsorbent polymer capable of entrapping solid particles and liquids and the product thereof
US5712358A (en) * 1995-06-07 1998-01-27 Amcol International Corporation Process for producing an oil sorbent copolymer and the product thereof
JPH09226852A (ja) * 1996-02-28 1997-09-02 Cci Corp 塗布容器
JPH11222272A (ja) * 1998-02-02 1999-08-17 Tombow Pencil Co Ltd 液体のり容器
US6013637A (en) * 1998-06-12 2000-01-11 Dermik Laboratories Inc. Anti-acne method and composition
US6110446A (en) * 1998-10-05 2000-08-29 Colgate Palmolive Company Dual component antiplaque and tooth whitening composition
US6007264A (en) * 1998-12-02 1999-12-28 Felix Investments, Llc Integral package applicator
CA2309373A1 (en) * 1999-05-27 2000-11-27 Johnson & Johnson Consumer Companies, Inc. Novel topical formulations
US7758888B2 (en) * 2000-04-21 2010-07-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
EP1335693A2 (en) * 2000-04-21 2003-08-20 Sol-Gel Technologies Ltd. Composition exhibiting enhanced formulation stability and delivery of topical active ingredients
WO2001091726A1 (en) * 2000-06-02 2001-12-06 Dermik International Holding Inc. Acne-treating composition
JP4580524B2 (ja) * 2000-09-12 2010-11-17 株式会社日本点眼薬研究所 フィルター付き吐出容器
US6462025B2 (en) * 2000-12-12 2002-10-08 Imaginative Research Associates, Inc. Antibiotic/benzoyl peroxide dispenser
US6544562B2 (en) * 2001-06-25 2003-04-08 Blistex Inc. Acne treatment including dual-package system

Also Published As

Publication number Publication date
ATE509616T1 (de) 2011-06-15
KR20050105442A (ko) 2005-11-04
EA008813B1 (ru) 2007-08-31
WO2004064803A1 (en) 2004-08-05
AU2004206101B2 (en) 2010-06-24
GB0301577D0 (en) 2003-02-26
HK1088540A1 (en) 2006-11-10
CN1764437B (zh) 2010-05-12
JP2006519178A (ja) 2006-08-24
MA27586A1 (fr) 2005-10-03
EP1589945B1 (en) 2011-05-18
NZ541370A (en) 2008-08-29
AU2004206101A2 (en) 2004-08-05
KR101224065B1 (ko) 2013-01-21
CA2514019C (en) 2012-02-28
MXPA05007785A (es) 2006-05-04
AU2004206101A1 (en) 2004-08-05
EA200501107A1 (ru) 2006-02-24
JP4898423B2 (ja) 2012-03-14
EP1589945A1 (en) 2005-11-02
CA2514019A1 (en) 2004-08-05
DK1589945T3 (da) 2011-09-05
CN1764437A (zh) 2006-04-26
US20040157766A1 (en) 2004-08-12
ZA200505925B (en) 2006-11-29

Similar Documents

Publication Publication Date Title
BRPI0406911A (pt) Produto farmacêutico e/ou cosmético
EA200401252A1 (ru) Микрочастицы лекарственных веществ
SE0003449D0 (sv) Anticancer compositions
WO2004054542A3 (en) Oral drug delivery system comprising high viscosity liquid carrier materials
MXPA05010565A (es) Sistemas de suminsitro de farmacos que comprenden un ingrediente activo encapsulado.
WO2005046640A3 (en) Multi-site drug delivery platform
NO953278D0 (no) Fremgangsmåter for in vivo-levering av biologisk aktive stoffer og sammensetninger som er nyttige for dette
ATE251449T1 (de) Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
ATE356612T1 (de) Orale, pharmazeutische darreichungsformen von flüssigen medikamenten mitverbesserter bioverfügbarkeit
AU2001296865A1 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
DE60004797D1 (de) Arzneimittel mit verzögerter wirkstoffabgabe enthaltend isoquercetin und ascorbinsäure
CA2494473A1 (en) Stabilized protein compositions for topical administration and methods of making same
WO2006060325A3 (en) Coated drug delivery formulations
ATE442864T1 (de) Pharmazeutische zusammensetzung mit einem organopolysiloxan-elastomer und einem lösungsmittel-aktivwirkstoff
NO20073575L (no) Farmasoytiske sammensetninger for behandling av cellulitt
WO2006091719A3 (en) Compositions and methods enhancing transdermal delivery of drugs and biologics
ATE311904T1 (de) Halbfester verabreichungsträger und arzneimittel
CY1107295T1 (el) Σταθεροποιηση στερεων φορμουλων φαρμακων του θυρεοειδους
IL179177A (en) A pharmaceutical product including acyclovir and delivery compound, dosage unit, use of acyclovir in the preparation of the pharmaceutical product, use of the pharmaceutical product in the preparation of a drug and a method for the preparation of the pharmaceutical product
TN2010000008A1 (en) Oral pharmaceutical solutions containing telbivudine
JO2492B1 (en) A pharmaceutical formula in the form of aqueous gel for the skin use of its active ingredients
CA2185883A1 (en) The use of dimeticone as a transport and carrier system and/or drug delivery system
MY141008A (en) Oral formulations of deoxypeganine and their uses
PT1144420E (pt) Fosfatidilinositois sulfatados a sua preparacao e a sua utilizacao
SE0203817D0 (sv) New composition

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 12A ANUIDADE.

B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2344 DE 08-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.

B15K Others concerning applications: alteration of classification

Ipc: A61Q 19/08 (2006.01), A61K 8/02 (2006.01), A61K 8/